BioVaxys Technology Corp.
BVAXF · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Market Cap | $15 | $2 | $20 | $31 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $14 | $2 | $20 | $30 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | $0 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$8 | -$12 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.202 | -0.573 | -1.2 | -0.779 |
| % Growth | 64.7% | 52.3% | -54% | – |
| Operating Cash Flow | -$2 | -$1 | -$2 | -$5 |
| Capital Expenditures | -$1 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$1 | -$2 | -$5 |